Contributor Page
Arnold & Porter
 
Email  |  Website  |  Articles
Contact Details
Tel: +1 202 942.5000
Fax: +1 202 942.5999
601 Mass. Ave., NW
Washington, DC
DC 20001-3743
United States
By Daniel Kracov, Evelina J. Norwinski, Raqiyyah Pippins
On December 11, 2018, Congress took an initial step toward legalizing cannabis and to resolve
By Arnold & Porter Kaye Scholer LLP
Families that endured lasting emotional and physical suffering under deliberately cruel policy seek to hold government accountable.
By Kenneth Chernof, John D. Lombardo, Daphne Morduchowitz, Andrew K. Solow, David J. Weiner, Michael S. Bullerman, Tiffany Ikeda, Paul Beavers, Tommy Huynh, Michael Kientzle, Colleen Lima
In Henry Schein, Inc. v. Archer & White Sales, Inc., No. 17-1212, Justice Kavanaugh delivered his first written opinion for the Supreme Court.
By Brian Lohan, Ginger Clements
On January 17, 2019, the Fifth Circuit Court of Appeals (Appellate Court) overruled the decision of the United States Bankruptcy Court for the Southern District of Texas (Bankruptcy Court)
By Ewan Townsend, Bonnie Clemence
The Falsified Medicines Directive 2011/62/EU (FMD) introduced a new requirement for safety features to appear on the packaging of all prescription-only medicinal products: a unique product identifier and an anti-tampering device (ATD).
By Samuel Goodman
Thousands of European and U.S. companies will have been relieved by the recent announcement that the EU-U.S. Privacy Shield is secure for another year.
By Steven Benz, John Gould, Jeffrey Handwerker, Kristin Hicks, Matthew T. Fornataro, Rosemary Maxwell, Ashley Bender, Catherine A. Brandon, Vicky Gormanly, Nicole Leon, Ariane M. Horn, Nora Schneider
On January 31, 2019, the Department of HHS Office of Inspector General released a Proposed Rule on Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of...
By Andrew Bauer, Jonathan Green, Daniel Hawke
Late last week, former SAC Capital Advisors portfolio manager Mathew Martoma petitioned the Supreme Court to review his 2014 conviction for insider trading. Martoma's conviction stems ...
By Teresa Johnson, Catrine Galler Brown
California is known for thinking out of the box and being ahead of the curve in many ways, and that includes the regulation of non-bank lenders.
By Arturo Caraballo, Rashmi Seth
In the fall of 2017, the Board of Governors of the Federal Reserve System, the Federal Deposit Insurance Corporation and the Office of the Comptroller of the Currency promulgated new rules...
By Bonnie Clemence, Jacqueline Mulryne
As we approach one year to go before the application of Regulations (EU) 745/2017 (Medical Devices) and 746/2017 (In Vitro Diagnostic Medical Devices) ...
By Lawrence E. Culleen, Michael D. Daneker, Sean Morris, Peggy Otum, Thomas Santoro
This quarterly newsletter provides updates on litigation, regulatory, legislative, and other notable developments involving chemicals of concern to business. Our present focus is on substances
By Paul J. Fishman, Amy Jeffress, Kristine Blackwood
The 116th Congress is poised to take an aggressive approach to investigations.
By Marcus Asner, Daniel Hawke, Michael Mancusi, Erik Walsh, Kevin Toomey
AML and sanctions compliance enforcement costs remain in the billions as financial institutions in the US continue to be challenged by new regulatory requirements and continuing enforcement action
By Stuart Turner, Nathaniel Castellano
In 2016, Congress instructed the U.S. DOD to convene a panel of procurement professionals from inside and outside government to review every regulation governing DOD procurement and recommend whether each one should...
Contributor's Topics
More...